Daniel M. Skovronsky

Affiliations: 
Founder and CEO Avid Radiopharmaceuticals, Philadelphia, PA, United States 
Website:
http://www.avidrp.com/aboutus/aboutus_management.html#daniel
Google:
"Daniel Skovronsky"
Cross-listing: Neurotree - Chemistry Tree

Parents

Sign in to add mentor
Nicholas K. Gonatas post-doc Penn
 (Early 1990's)
Virginia Man-Yee Lee post-doc Penn
 (Early 1990's)
John Q. Trojanowski post-doc Penn
 (Early 1990's)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dougan M, Azizad M, Mocherla B, et al. (2021) A randomized, placebo-controlled clinical trial of bamlanivimab and etesevimab together in high-risk ambulatory patients with COVID-19 and validation of the prognostic value of persistently high viral load. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America
Dougan M, Nirula A, Azizad M, et al. (2021) Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19. The New England Journal of Medicine
Cohen MS, Nirula A, Mulligan MJ, et al. (2021) Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial. Jama
Mintun MA, Lo AC, Duggan Evans C, et al. (2021) Donanemab in Early Alzheimer's Disease. The New England Journal of Medicine
Gottlieb RL, Nirula A, Chen P, et al. (2021) Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial. Jama
Nirula A, Shen L, Skovronsky DM. (2020) Neutralizing Antibody LY-CoV555 for Outpatient Covid-19. Reply. The New England Journal of Medicine. 384
Chen P, Nirula A, Heller B, et al. (2020) SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19. The New England Journal of Medicine
Grundman M, Johnson KA, Lu M, et al. (2016) Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria. Dementia and Geriatric Cognitive Disorders. 41: 80-92
Joshi AD, Pontecorvo MJ, Skovronsky DM, et al. (2015) A semi-automated method for quantification of florbetapir F 18 PET images. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Klunk WE, Koeppe RA, Price JC, et al. (2015) The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 1-15.e1-4
See more...